Febbo Phillip G. 4
4 · VERACYTE, INC. · Filed Mar 10, 2025
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
- Award
Common Stock
2025-03-06+24,160→ 106,700 total
Footnotes (1)
- [F1]Restricted stock units awarded on March 6, 2025 vest 25% on March 2, 2026 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.